Zymergen raises $400 million Series C

December 13, 2018
Accelerating Materials Innovation More...
Synthetic biology | Fertilizers More...
11177 thumb square
by Gihan Hewage
Truly disruptive

Zymergen had previously focused on improving its clients' strains – claiming scales over 100,000 tpa for strains and producing on the order of $100 million worth of product per year. Not only will Zymergen use this funding to double the capacity of its platform, but it also intends to use the funding to commercialize its own products. This raise highlights the strong potential for synthetic biology as a future manufacturing tool and ally to the agriculture industry – Zymergen's plan to commercialize strains from scratch, as opposed to optimizing existing strains, will provide a strong test of the efficacy of its platform, especially given the struggles of companies commercializing bio-based products in 2018.

For the original news article, click here .

Further Reading


Company Profile | January 21, 2019

Developed the catalytic microwave depolymerization (CMD) technology that recycles waste polystyrene to styrene monomers via microwave pyrolysis Pyrowave's CMD reactors have a processing capacity of 4.8 metric tons per day (MTPD) and offer a 90% yield of recycled styrene that exhibits equivalent... Not part of subscription


Company Profile | January 21, 2019

NovoNutrients is a developer of proprietary microbes and gas fermentation systems for converting carbon dioxide (CO2) into protein The company sources CO2 and hydrogen (H2) gases from industrial gas emissions to produce its fishmeal alternative, branded Novomeal; Novomeal is currently 68% ... Not part of subscription

Advonex International

Company Profile | January 17, 2019

Catalytically converts oils, fats, and greases to a mixture of hydrocabon products, including group III/IV base oils, paraffin wax, silicone replacements, mineral oil, and a small percentage of diesel and glycerol; claims there are few competing silicone replacements in the cosmetic industry and ... Not part of subscription